Literature DB >> 8056033

Dose-dependent T cell tolerance to an immunodominant self peptide.

J P Cabaniols1, R Cibotti, P Kourilsky, K Kosmatopoulos, J M Kanellopoulos.   

Abstract

We have previously described a model of tolerance to self peptides in a mouse transgenic (Tg) line producing secreted hen egg-white lysozyme (HEL). The HEL cDNA was placed under the control of a ubiquitous promoter expressed early in embryogenesis, so that HEL should be present in Tg mice throughout the development of the immune system. Since individual HEL Tg mice express different amounts of serum HEL, we were previously able to show that H-2d mice with HEL blood level > 10 ng/ml are tolerant to HEL and to the immunodominant (ID) peptide 108-116. However, autoreactive T lymphocytes recognizing the HEL subdominant (SD) peptides 74-96 and 1-18 still persist and the SD-specific response disappear at higher blood HEL concentrations. In the present work, we have studied HEL Tg H-2d mice with HEL serum levels < 10 ng/ml (HEL-low Tg animals). We find that 50% of Tg animals with HEL blood concentration < 2 ng/ml are responsive to HEL in T cell proliferation assays, although these responses are lower than those seen in non-Tg control mice. The HEL-specific T lymphocytes react only with 15-mer overlapping peptides encompassing the single H-2d ID region of HEL (residues 102-122); whereas the 9-mer minimal ID peptide 108-116, which strongly triggers non-Tg T cells, is unable to stimulate auto-reactive T cells in vitro from HEL-low Tg mice. Altogether, our results suggest that T lymphocytes specific for the minimal ID peptide are deleted or inactivated, while T cell clones of lower affinity and reacting with epitopes on longer peptides persist. Thus, the high affinity ID peptide-specific T cell clones can be negatively selected even in the presence of low amounts of HEL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056033     DOI: 10.1002/eji.1830240804

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  An affinity/avidity model of peripheral T cell regulation.

Authors:  Hong Jiang; Yilun Wu; Bitao Liang; Zongyu Zheng; Guomei Tang; Jean Kanellopoulos; Mark Soloski; Robert Winchester; Itamar Goldstein; Leonard Chess
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 2.  Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.

Authors:  William C Watt; Denise L Cecil; Mary L Disis
Journal:  Semin Immunopathol       Date:  2016-12-14       Impact factor: 9.623

3.  T-cell tolerance induction is normal in the (NZB x NZW)F1 murine model of systemic lupus erythematosus.

Authors:  J Wither; B Vukusic
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

4.  Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.

Authors:  T H Thatcher; D P O'Brien; S Altuwaijri; R K Barth
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

Review 5.  Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.

Authors:  Jeanne Menez-Jamet; Catherine Gallou; Aude Rougeot; Kostas Kosmatopoulos
Journal:  Ann Transl Med       Date:  2016-07

6.  In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.

Authors:  Todd D Schell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 7.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

8.  Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.

Authors:  E V Fedoseyeva; R C Tam; P L Orr; M R Garovoy; G Benichou
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.

Authors:  P O Campos-Lima; V Levitsky; M P Imreh; R Gavioli; M G Masucci
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

10.  Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.

Authors:  Matthew N Davies; Jagadeesh Bayry; Elma Z Tchilian; Janakiraman Vani; Melkote S Shaila; Emily K Forbes; Simon J Draper; Peter C L Beverley; David F Tough; Darren R Flower
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.